BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26187570)

  • 1. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement.
    Reginster JY; Reiter-Niesert S; Bruyère O; Berenbaum F; Brandi ML; Branco J; Devogelaer JP; Herrero-Beaumont G; Kanis J; Maggi S; Maheu E; Richette P; Rizzoli R; Cooper C
    Osteoarthritis Cartilage; 2015 Dec; 23(12):2086-2093. PubMed ID: 26187570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on recent therapeutic guidelines for osteoarthritis.
    Cutolo M; Berenbaum F; Hochberg M; Punzi L; Reginster JY
    Semin Arthritis Rheum; 2015 Jun; 44(6):611-7. PubMed ID: 25677861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting.
    Bruyère O; Cooper C; Pelletier JP; Maheu E; Rannou F; Branco J; Luisa Brandi M; Kanis JA; Altman RD; Hochberg MC; Martel-Pelletier J; Reginster JY
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S3-11. PubMed ID: 26806188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
    Abadie E; Ethgen D; Avouac B; Bouvenot G; Branco J; Bruyere O; Calvo G; Devogelaer JP; Dreiser RL; Herrero-Beaumont G; Kahan A; Kreutz G; Laslop A; Lemmel EM; Nuki G; Van De Putte L; Vanhaelst L; Reginster JY;
    Osteoarthritis Cartilage; 2004 Apr; 12(4):263-8. PubMed ID: 15023377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Bruyère O; Cooper C; Al-Daghri NM; Dennison EM; Rizzoli R; Reginster JY
    Aging Clin Exp Res; 2018 Feb; 30(2):111-117. PubMed ID: 29177637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-surgical treatments for the management of early osteoarthritis.
    Filardo G; Kon E; Longo UG; Madry H; Marchettini P; Marmotti A; Van Assche D; Zanon G; Peretti GM
    Knee Surg Sports Traumatol Arthrosc; 2016 Jun; 24(6):1775-85. PubMed ID: 27043347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
    Maheu E; Rannou F; Reginster JY
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S28-33. PubMed ID: 26806183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)].
    Aubry-Rozier B
    Rev Med Suisse; 2012 Mar; 8(332):571-2, 574, 576. PubMed ID: 22455150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.
    Bannuru RR; Schmid CH; Kent DM; Vaysbrot EE; Wong JB; McAlindon TE
    Ann Intern Med; 2015 Jan; 162(1):46-54. PubMed ID: 25560713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical review of chondroitin sulfate in osteoarthritis.
    Uebelhart D
    Osteoarthritis Cartilage; 2008; 16 Suppl 3():S19-21. PubMed ID: 18674931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of the evidence about drugs used as SYSADOA].
    Sanfélix-Gimeno G; Reig-Mollá B; Sanfélix-Genovés J; Giner-Ruiz V
    Med Clin (Barc); 2007 Nov; 129(16):624-8. PubMed ID: 18001676
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological therapies for osteoarthritis].
    Richette P
    Therapie; 2011; 66(5):383-90. PubMed ID: 22031681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Honvo G; Bannuru RR; Bruyère O; Rannou F; Herrero-Beaumont G; Uebelhart D; Cooper C; Arden N; Conaghan PG; Reginster JY; Thomas T; McAlindon T
    Drugs Aging; 2019 Apr; 36(Suppl 1):145-159. PubMed ID: 31073927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents.
    Gallagher B; Tjoumakaris FP; Harwood MI; Good RP; Ciccotti MG; Freedman KB
    Am J Sports Med; 2015 Mar; 43(3):734-44. PubMed ID: 24866892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
    Gregori D; Giacovelli G; Minto C; Barbetta B; Gualtieri F; Azzolina D; Vaghi P; Rovati LC
    JAMA; 2018 Dec; 320(24):2564-2579. PubMed ID: 30575881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating knee osteoarthritis with intra-articular hyaluronans.
    Brzusek D; Petron D
    Curr Med Res Opin; 2008 Dec; 24(12):3307-22. PubMed ID: 18954498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint.
    Zhang Z; Huang C; Cao Y; Mu R; Zhang MC; Xing D; Fan D; Ding Y; Guo J; Hou Y; Jianhao L; Veronese N; Reginster JY; Bruyere O; Cavalier E; Zhang H
    Aging Clin Exp Res; 2021 Aug; 33(8):2141-2147. PubMed ID: 34189714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosamine oral administration as an adjunct to hyaluronic acid injection in treating temporomandibular joint osteoarthritis.
    Cen X; Liu Y; Wang S; Yang X; Shi Z; Liang X
    Oral Dis; 2018 Apr; 24(3):404-411. PubMed ID: 28862770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
    Bruyère O; Altman RD; Reginster JY
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S12-7. PubMed ID: 26806187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.